Artia Global Partners »

Cidara Therapeutics shares owned by Artia Global Partners

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $16M 71k 220.89

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Proshares Tr Ii Ultra Gold (UGL)
Soleno Therapeutics (SLNO)
Viking Therapeutics (VKTX)
Trevi Therapeutics (TRVI)
Uniqure Nv SHS (QURE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Astrazeneca Sponsored Adr
Cidara Therapeutics Com New (CDTX)
Eyepoint Pharmaceuticals Com New (EYPT)
Ionis Pharmaceuticals (IONS)
Dianthus Therapeutics (DNTH)

View all positions for Artia Global Partners

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics